| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.926 | 0.001 | 0.936 | Tyrosine 3 hydroxylase inhibitor | 0.929 0.001 DB00279 0.936 0.001 DBMET02273 0.927 0.001 DBMET02578 | DBMET02273 | |
| 0.823 | 0.001 | 0.823 | NMDA receptor subunit 3A antagonist | 0.815 0.001 DB00279 0.75 0.002 DBMET02273 0.706 0.002 DBMET02578 | ||
| 0.78 | 0.001 | 0.78 | NMDA receptor subunit 3B antagonist | 0.65 0.002 DB00279 0.691 0.002 DBMET02273 0.634 0.002 DBMET02578 | ||
| 0.78 | 0.004 | 0.78 | Cholesterol antagonist | 0.727 0.006 DB00279 0.726 0.006 DBMET02273 0.729 0.006 DBMET02578 | ||
| 0.77 | 0.006 | 0.782 | Thyroid hormone antagonist | 0.782 0.005 DB00279 0.617 0.017 DBMET02273 0.644 0.014 DBMET02578 | DB00279 | |
| 0.758 | 0 | 0.758 | Thyroid hormone alpha agonist | 0.71 0 DB00279 0.546 0.001 DBMET02273 0.526 0.001 DBMET02578 | ||
| 0.757 | 0.006 | 0.757 | Angiogenesis inhibitor | 0.607 0.016 DB00279 0.539 0.023 DBMET02273 0.553 0.022 DBMET02578 | ||
| 0.72 | 0.003 | 0.72 | NMDA receptor antagonist | 0.719 0.003 DB00279 0.704 0.003 DBMET02273 0.555 0.004 DBMET02578 | ||
| 0.688 | 0.002 | 0.879 | Thyroid hormone alpha antagonist | 0.879 0.001 DB00279 0.513 0.002 DBMET02273 0.344 0.002 DBMET02578 | DB00279 | |
| 0.677 | 0.001 | 0.706 | Thyroid hormone agonist | 0.706 0.001 DB00279 0.592 0.001 DBMET02273 0.69 0.001 DBMET02578 | DB00279 | |
| 0.594 | 0.003 | 0.748 | Cystathionine beta-synthase inhibitor | 0.614 0.003 DB00279 0.748 0.002 DBMET02273 0.592 0.003 DBMET02578 | DBMET02273 | |
| 0.581 | 0.002 | 0.635 | Sodium/bile acid cotransporter inhibitor | 0.635 0.001 DB00279 0.544 0.003 DBMET02273 0.505 0.004 DBMET02578 | DB00279 | |
| 0.563 | 0.001 | 0.681 | DOPA decarboxylase inhibitor | 0.574 0.001 DB00279 0.681 0 DBMET02273 0.506 0.001 DBMET02578 | DBMET02273 | |
| 0.542 | 0.01 | 0.542 | Angiogenesis stimulant | 0.434 0.017 DB00279 0.391 0.023 DBMET02273 0.512 0.011 DBMET02578 | ||
| 0.518 | 0.029 | 0.534 | Thyroid hormone beta antagonist | 0.534 0.026 DB00279 0.374 0.061 DBMET02273 0.393 0.056 DBMET02578 | DB00279 | |
| 0.464 | 0.006 | 0.497 | 5 Hydroxytryptamine uptake stimulant | 0.47 0.005 DB00279 0.497 0.004 DBMET02273 0.475 0.005 DBMET02578 | DBMET02273 | |
| 0.449 | 0.001 | 0.476 | Thyroid hormone beta agonist | 0.476 0.001 DB00279 0.352 0.001 DBMET02273 0.339 0.001 DBMET02578 | DB00279 | |
| 0.493 | 0.052 | 0.504 | Cyclophilin D inhibitor | 0.504 0.049 DB00279 0.472 0.059 DBMET02273 0.406 0.087 DBMET02578 | DB00279 | |
| 0.439 | 0.003 | 0.439 | Farnesoid X receptor antagonist | 0.379 0.004 DB00279 0.357 0.004 DBMET02273 0.357 0.004 DBMET02578 | ||
| 0.445 | 0.016 | 0.445 | Psychostimulant | 0.433 0.018 DB00279 0.439 0.017 DBMET02273 0.43 0.018 DBMET02578 | ||
| 0.403 | 0.004 | 0.403 | Aminoacyl-tRNA synthetase inhibitor | 0.397 0.004 DB00279 0.383 0.004 DBMET02273 0.39 0.004 DBMET02578 | ||
| 0.478 | 0.081 | 0.478 | Apoptosis agonist | 0.437 0.097 DB00279 0.455 0.089 DBMET02273 0.333 0.15 DBMET02578 | ||
| 0.435 | 0.056 | 0.479 | Transcription factor NF kappa B inhibitor | 0.444 0.054 DB00279 0.479 0.047 DBMET02273 0.443 0.054 DBMET02578 | DBMET02273 | |
| 0.36 | 0.006 | 0.368 | Glutamate receptor antagonist | 0.346 0.007 DB00279 0.368 0.006 DBMET02273 0.27 0.013 DBMET02578 | DBMET02273 | |
| 0.355 | 0.005 | 0.362 | Glutamate dehydrogenase inhibitor | 0.314 0.005 DB00279 0.362 0.004 DBMET02273 0.304 0.005 DBMET02578 | DBMET02273 | |
| 0.339 | 0.004 | 0.457 | Phenylalanine 4-hydroxylase inhibitor | 0.352 0.003 DB00279 0.457 0.003 DBMET02273 0.352 0.003 DBMET02578 | DBMET02273 | |
| 0.378 | 0.043 | 0.379 | Vasodilator, coronary | 0.315 0.076 DB00279 0.377 0.043 DBMET02273 0.379 0.043 DBMET02578 | DBMET02578 | |
| 0.367 | 0.038 | 0.385 | Interleukin 2 agonist | 0.361 0.041 DB00279 0.385 0.032 DBMET02273 0.358 0.042 DBMET02578 | DBMET02273 | |
| 0.363 | 0.037 | 0.463 | DNA damaging | 0.454 0.019 DB00279 0.463 0.018 DBMET02273 0.245 0.083 DBMET02578 | DBMET02273 | |
| 0.357 | 0.034 | 0.385 | Hypolipemic | 0.385 0.028 DB00279 0.282 0.055 DBMET02273 0.184 0.106 DBMET02578 | DB00279 | |
| 0.323 | 0.002 | 0.323 | Purinergic P2X2 antagonist | 0.319 0.002 DB00279 0.232 0.003 DBMET02273 0.315 0.002 DBMET02578 | ||
| 0.308 | 0.004 | 0.489 | NMDA 2A receptor antagonist | 0.3 0.004 DB00279 0.489 0.003 DBMET02273 0.305 0.004 DBMET02578 | DBMET02273 | |
| 0.297 | 0.006 | 0.397 | Histidine decarboxylase inhibitor | 0.299 0.006 DB00279 0.397 0.004 DBMET02273 0.293 0.007 DBMET02578 | DBMET02273 | |
| 0.29 | 0.003 | 0.29 | Bile acid receptor antagonist | 0.233 0.004 DB00279 0.244 0.004 DBMET02273 0.235 0.004 DBMET02578 | ||
| 0.311 | 0.035 | 0.454 | Peroxidase inhibitor | 0.326 0.032 DB00279 0.454 0.014 DBMET02273 0.298 0.038 DBMET02578 | DBMET02273 | |
| 0.327 | 0.071 | 0.387 | Immunostimulant | 0.32 0.073 DB00279 0.387 0.054 DBMET02273 0.368 0.059 DBMET02578 | DBMET02273 | |
| 0.252 | 0.003 | 0.298 | Glutamate (mGluR3) antagonist | 0.244 0.003 DB00279 0.298 0.003 DBMET02273 0.248 0.003 DBMET02578 | DBMET02273 | |
| 0.268 | 0.026 | 0.268 | Protein-tyrosine phosphatase inhibitor | 0.241 0.033 DB00279 0.264 0.027 DBMET02273 0.263 0.028 DBMET02578 | ||
| 0.251 | 0.013 | 0.274 | Aminopeptidase B inhibitor | 0.244 0.014 DB00279 0.274 0.01 DBMET02273 0.243 0.014 DBMET02578 | DBMET02273 | |
| 0.29 | 0.054 | 0.402 | Superoxide dismutase inhibitor | 0.296 0.052 DB00279 0.402 0.026 DBMET02273 0.299 0.051 DBMET02578 | DBMET02273 | |
| 0.312 | 0.081 | 0.395 | Antithrombotic | 0.308 0.083 DB00279 0.395 0.05 DBMET02273 0.308 0.083 DBMET02578 | DBMET02273 | |
| 0.282 | 0.053 | 0.321 | Pyruvate kinase inhibitor | 0.195 0.084 DB00279 0.321 0.042 DBMET02273 0.298 0.048 DBMET02578 | DBMET02273 | |
| 0.294 | 0.069 | 0.306 | Hypoxia-inducible factor 1 alpha inhibitor | 0.306 0.063 DB00279 0.254 0.097 DBMET02273 0.218 0.131 DBMET02578 | DB00279 | |
| 0.238 | 0.018 | 0.298 | Chelator | 0.238 0.018 DB00279 0.298 0.011 DBMET02273 0.135 0.042 DBMET02578 | DBMET02273 | |
| 0.289 | 0.074 | 0.308 | Spasmolytic | 0.183 0.134 DB00279 0.308 0.067 DBMET02273 0.293 0.072 DBMET02578 | DBMET02273 | |
| 0.253 | 0.043 | 0.289 | Growth hormone agonist | 0.25 0.043 DB00279 0.289 0.034 DBMET02273 0.25 0.043 DBMET02578 | DBMET02273 | |
| 0.223 | 0.017 | 0.223 | GABA C receptor agonist | 0.195 0.021 DB00279 0.223 0.017 DBMET02273 0.17 0.027 DBMET02578 | ||
| 0.233 | 0.029 | 0.249 | Succinate dehydrogenase inhibitor | 0.233 0.029 DB00279 0.249 0.023 DBMET02273 0.225 0.033 DBMET02578 | DBMET02273 | |
| 0.323 | 0.119 | 0.364 | Antibacterial | 0.306 0.131 DB00279 0.364 0.094 DBMET02273 0.285 0.147 DBMET02578 | DBMET02273 | |
| 0.21 | 0.008 | 0.398 | NMDA 2 receptor antagonist | 0.213 0.008 DB00279 0.398 0.004 DBMET02273 0.222 0.008 DBMET02578 | DBMET02273 | |
| 0.203 | 0.005 | 0.223 | NMDA receptor agonist | 0.184 0.005 DB00279 0.223 0.004 DBMET02273 0.182 0.005 DBMET02578 | DBMET02273 | |
| 0.268 | 0.071 | 0.316 | Cardiotonic | 0.288 0.062 DB00279 0.316 0.05 DBMET02273 | DBMET02273 | |
| 0.2 | 0.004 | 0.344 | GABA aminotransferase inhibitor | 0.198 0.004 DB00279 0.344 0.003 DBMET02273 0.203 0.004 DBMET02578 | DBMET02273 | |
| 0.221 | 0.028 | 0.221 | Alpha-N-acetylglucosaminidase inhibitor | 0.195 0.036 DB00279 0.221 0.028 DBMET02273 0.193 0.036 DBMET02578 | ||
| 0.216 | 0.025 | 0.216 | Protein-tyrosine phosphatase 1B inhibitor | 0.191 0.031 DB00279 0.207 0.027 DBMET02273 0.213 0.026 DBMET02578 | ||
| 0.188 | 0.003 | 0.241 | AMPA 4 receptor antagonist | 0.154 0.004 DB00279 0.241 0.003 DBMET02273 0.142 0.004 DBMET02578 | DBMET02273 | |
| 0.192 | 0.007 | 0.192 | Peroxisome proliferator-activated receptor gamma agonist | 0.188 0.008 DB00279 0.142 0.015 DBMET02273 0.176 0.009 DBMET02578 | ||
| 0.183 | 0.004 | 0.183 | Vitronectin receptor antagonist | 0.155 0.004 DB00279 0.096 0.005 DBMET02273 0.062 0.005 DBMET02578 | ||
| 0.186 | 0.008 | 0.24 | Glutamate decarboxylase inhibitor | 0.182 0.009 DB00279 0.24 0.005 DBMET02273 0.178 0.009 DBMET02578 | DBMET02273 | |
| 0.185 | 0.013 | 0.185 | Selectin antagonist | 0.105 0.026 DB00279 0.131 0.02 DBMET02273 0.178 0.014 DBMET02578 | ||
| 0.186 | 0.016 | 0.191 | Vanilloid 1 agonist | 0.188 0.015 DB00279 0.187 0.016 DBMET02273 0.191 0.014 DBMET02578 | DBMET02578 | |
| 0.187 | 0.018 | 0.21 | Catalase inhibitor | 0.175 0.02 DB00279 0.21 0.013 DBMET02273 0.168 0.022 DBMET02578 | DBMET02273 | |
| 0.177 | 0.009 | 0.25 | Somatostatin 1 agonist | 0.25 0.004 DB00279 0.192 0.007 DBMET02273 0.173 0.009 DBMET02578 | DB00279 | |
| 0.252 | 0.088 | 0.394 | 5 Hydroxytryptamine release stimulant | 0.25 0.089 DB00279 0.394 0.047 DBMET02273 0.241 0.094 DBMET02578 | DBMET02273 | |
| 0.238 | 0.075 | 0.271 | DNA synthesis inhibitor | 0.228 0.085 DB00279 0.271 0.055 DBMET02273 0.217 0.098 DBMET02578 | DBMET02273 | |
| 0.313 | 0.151 | 0.391 | 5 Hydroxytryptamine release inhibitor | 0.314 0.149 DB00279 0.391 0.084 DBMET02273 0.316 0.148 DBMET02578 | DBMET02273 | |
| 0.18 | 0.019 | 0.201 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.174 0.02 DB00279 0.201 0.016 DBMET02273 0.174 0.02 DBMET02578 | DBMET02273 | |
| 0.165 | 0.004 | 0.175 | AMPA 2 receptor antagonist | 0.154 0.004 DB00279 0.175 0.004 DBMET02273 0.146 0.004 DBMET02578 | DBMET02273 | |
| 0.238 | 0.077 | 0.238 | Vasodilator | 0.178 0.123 DBMET02273 0.233 0.08 DBMET02578 | ||
| 0.186 | 0.029 | 0.236 | Cell adhesion inhibitor | 0.236 0.017 DB00279 0.226 0.019 DBMET02273 0.179 0.031 DBMET02578 | DB00279 | |
| 0.163 | 0.011 | 0.18 | Aminopeptidase I inhibitor | 0.153 0.012 DB00279 0.18 0.008 DBMET02273 0.153 0.012 DBMET02578 | DBMET02273 | |
| 0.155 | 0.004 | 0.211 | Kainate receptor antagonist | 0.141 0.005 DB00279 0.211 0.004 DBMET02273 0.137 0.005 DBMET02578 | DBMET02273 | |
| 0.161 | 0.01 | 0.161 | Argininosuccinate synthase inhibitor | 0.14 0.013 DB00279 0.161 0.01 DBMET02273 0.133 0.013 DBMET02578 | ||
| 0.151 | 0.002 | 0.163 | Kainate receptor agonist | 0.143 0.002 DB00279 0.163 0.002 DBMET02273 0.137 0.002 DBMET02578 | DBMET02273 | |
| 0.179 | 0.03 | 0.201 | Cathepsin H inhibitor | 0.175 0.031 DB00279 0.201 0.022 DBMET02273 0.176 0.031 DBMET02578 | DBMET02273 | |
| 0.154 | 0.006 | 0.157 | Glycine receptor agonist | 0.139 0.008 DB00279 0.157 0.006 DBMET02273 0.131 0.01 DBMET02578 | DBMET02273 | |
| 0.152 | 0.004 | 0.19 | Glutamate (mGluR4) antagonist | 0.153 0.004 DB00279 0.19 0.003 DBMET02273 0.153 0.004 DBMET02578 | DBMET02273 | |
| 0.152 | 0.004 | 0.195 | Glutamate (mGluR group III) antagonist | 0.152 0.004 DB00279 0.195 0.003 DBMET02273 0.151 0.004 DBMET02578 | DBMET02273 | |
| 0.213 | 0.071 | 0.349 | Amyloid beta aggregation inhibitor | 0.224 0.067 DB00279 0.349 0.035 DBMET02273 0.225 0.066 DBMET02578 | DBMET02273 | |
| 0.191 | 0.051 | 0.243 | Phospholipase C inhibitor | 0.19 0.051 DB00279 0.243 0.026 DBMET02273 0.191 0.05 DBMET02578 | DBMET02273 | |
| 0.183 | 0.047 | 0.226 | Neurotensin receptor agonist | 0.186 0.044 DB00279 0.226 0.025 DBMET02273 0.185 0.045 DBMET02578 | DBMET02273 | |
| 0.136 | 0.004 | 0.155 | Glutamate (mGluR7) antagonist | 0.138 0.004 DB00279 0.155 0.003 DBMET02273 0.135 0.004 DBMET02578 | DBMET02273 | |
| 0.132 | 0.014 | 0.139 | Ribonucleoside-diphosphate reductase inhibitor | 0.129 0.014 DB00279 0.139 0.013 DBMET02273 0.127 0.015 DBMET02578 | DBMET02273 | |
| 0.123 | 0.005 | 0.126 | Glutamate (mGluR6) antagonist | 0.116 0.006 DB00279 0.126 0.005 DBMET02273 0.113 0.007 DBMET02578 | DBMET02273 | |
| 0.232 | 0.115 | 0.286 | Insulysin inhibitor | 0.227 0.12 DB00279 0.286 0.068 DBMET02273 0.23 0.116 DBMET02578 | DBMET02273 | |
| 0.144 | 0.029 | 0.144 | Adenylate kinase inhibitor | 0.13 0.036 DB00279 0.144 0.029 DBMET02273 0.123 0.041 DBMET02578 | ||
| 0.135 | 0.021 | 0.135 | Chymotrypsin inhibitor | 0.093 0.041 DB00279 0.108 0.031 DBMET02273 0.129 0.022 DBMET02578 | ||
| 0.129 | 0.015 | 0.129 | Vanilloid agonist | 0.128 0.015 DB00279 0.107 0.026 DBMET02273 0.128 0.015 DBMET02578 | ||
| 0.146 | 0.033 | 0.171 | Photosensitizer | 0.138 0.039 DB00279 0.171 0.021 DBMET02273 0.133 0.044 DBMET02578 | DBMET02273 | |
| 0.127 | 0.016 | 0.133 | Ribonucleotide reductase inhibitor | 0.124 0.016 DB00279 0.133 0.014 DBMET02273 0.122 0.016 DBMET02578 | DBMET02273 | |
| 0.11 | 0.004 | 0.119 | Kainate receptor 2 antagonist | 0.101 0.005 DB00279 0.119 0.004 DBMET02273 0.097 0.005 DBMET02578 | DBMET02273 | |
| 0.201 | 0.097 | 0.307 | Free radical scavenger | 0.209 0.091 DB00279 0.307 0.05 DBMET02273 0.208 0.091 DBMET02578 | DBMET02273 | |
| 0.118 | 0.016 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.106 0.019 DB00279 0.118 0.016 DBMET02273 0.095 0.022 DBMET02578 | ||
| 0.142 | 0.039 | 0.161 | DNA repair enzyme inhibitor | 0.14 0.041 DB00279 0.161 0.023 DBMET02273 0.114 0.085 DBMET02578 | DBMET02273 | |
| 0.123 | 0.021 | 0.2 | Keratolytic | 0.129 0.019 DB00279 0.2 0.008 DBMET02273 0.131 0.018 DBMET02578 | DBMET02273 | |
| 0.111 | 0.013 | 0.183 | NMDA 2C receptor antagonist | 0.107 0.014 DB00279 0.183 0.005 DBMET02273 0.106 0.014 DBMET02578 | DBMET02273 | |
| 0.167 | 0.069 | 0.205 | Thrombolytic | 0.167 0.07 DB00279 0.205 0.049 DBMET02273 0.165 0.071 DBMET02578 | DBMET02273 | |
| 0.121 | 0.025 | 0.126 | Phosphofructokinase-1 inhibitor | 0.111 0.028 DB00279 0.126 0.023 DBMET02273 0.102 0.031 DBMET02578 | DBMET02273 | |
| 0.125 | 0.031 | 0.128 | Interleukin 1 beta converting enzyme inhibitor | 0.097 0.062 DB00279 0.128 0.029 DBMET02273 0.123 0.033 DBMET02578 | DBMET02273 | |
| 0.134 | 0.042 | 0.156 | Nav1.4 sodium channel blocker | 0.134 0.042 DB00279 0.156 0.031 DBMET02273 0.133 0.042 DBMET02578 | DBMET02273 | |
| 0.095 | 0.004 | 0.127 | Kainate receptor 1 antagonist | 0.084 0.004 DB00279 0.127 0.003 DBMET02273 0.081 0.004 DBMET02578 | DBMET02273 | |
| 0.106 | 0.015 | 0.106 | Ornithine carbamoyltransferase inhibitor | 0.094 0.017 DB00279 0.106 0.015 DBMET02273 0.089 0.019 DBMET02578 | ||
| 0.107 | 0.017 | 0.125 | Carbonic anhydrase stimulant | 0.103 0.018 DB00279 0.125 0.014 DBMET02273 0.101 0.018 DBMET02578 | DBMET02273 | |
| 0.182 | 0.094 | 0.223 | Insulin sensitizer | 0.188 0.086 DB00279 0.223 0.052 DBMET02273 0.191 0.083 DBMET02578 | DBMET02273 | |
| 0.1 | 0.016 | 0.104 | NMDA receptor glycine site agonist | 0.093 0.02 DB00279 0.104 0.014 DBMET02273 0.092 0.021 DBMET02578 | DBMET02273 | |
| 0.129 | 0.046 | 0.16 | Mucolytic | 0.132 0.044 DB00279 0.16 0.027 DBMET02273 0.128 0.047 DBMET02578 | DBMET02273 | |
| 0.083 | 0.002 | 0.087 | Tryptophan hydroxylase 1 inhibitor | 0.078 0.002 DB00279 0.087 0.002 DBMET02273 0.074 0.002 DBMET02578 | DBMET02273 | |
| 0.189 | 0.108 | 0.354 | Antiamyloidogenic | 0.194 0.104 DB00279 0.354 0.038 DBMET02273 0.194 0.103 DBMET02578 | DBMET02273 | |
| 0.162 | 0.082 | 0.162 | ATPase inhibitor | 0.158 0.088 DBMET02273 0.157 0.089 DBMET02578 | ||
| 0.119 | 0.039 | 0.119 | Uric acid excretion stimulant | 0.101 0.052 DBMET02273 0.117 0.04 DBMET02578 | ||
| 0.086 | 0.006 | 0.086 | Retinoid X alpha receptor agonist | 0.054 0.013 DB00279 0.044 0.017 DBMET02273 0.056 0.012 DBMET02578 | ||
| 0.108 | 0.028 | 0.151 | Opioid delta receptor antagonist | 0.117 0.026 DB00279 0.151 0.019 DBMET02273 0.107 0.029 DBMET02578 | DBMET02273 | |
| 0.111 | 0.033 | 0.124 | Ornithine decarboxylase inhibitor | 0.108 0.036 DB00279 0.124 0.023 DBMET02273 0.11 0.034 DBMET02578 | DBMET02273 | |
| 0.079 | 0.004 | 0.081 | AMPA receptor agonist | 0.077 0.004 DB00279 0.081 0.004 DBMET02273 0.075 0.004 DBMET02578 | DBMET02273 | |
| 0.093 | 0.018 | 0.099 | 5 Hydroxytryptamine 2A agonist | 0.095 0.017 DB00279 0.099 0.015 DBMET02273 0.092 0.018 DBMET02578 | DBMET02273 | |
| 0.145 | 0.071 | 0.161 | Adenylate cyclase stimulant | 0.143 0.075 DB00279 0.161 0.047 DBMET02273 0.14 0.082 DBMET02578 | DBMET02273 | |
| 0.081 | 0.007 | 0.081 | Fumarate hydratase inhibitor | 0.07 0.008 DB00279 0.081 0.007 DBMET02273 0.063 0.01 DBMET02578 | ||
| 0.188 | 0.116 | 0.211 | Peptidyltransferase inhibitor | 0.187 0.118 DB00279 0.211 0.086 DBMET02273 0.186 0.119 DBMET02578 | DBMET02273 | |
| 0.079 | 0.008 | 0.097 | VLA-4 antagonist | 0.094 0.006 DB00279 0.097 0.006 DBMET02273 0.074 0.009 DBMET02578 | DBMET02273 | |
| 0.082 | 0.012 | 0.086 | Epithelial sodium channel blocker | 0.083 0.011 DB00279 0.086 0.01 DBMET02273 0.084 0.011 DBMET02578 | DBMET02273 | |
| 0.078 | 0.009 | 0.103 | Leukotriene A4 hydrolase inhibitor | 0.083 0.008 DB00279 0.103 0.005 DBMET02273 0.082 0.008 DBMET02578 | DBMET02273 | |
| 0.112 | 0.044 | 0.159 | Prolactin inhibitor | 0.114 0.043 DB00279 0.159 0.019 DBMET02273 0.108 0.048 DBMET02578 | DBMET02273 | |
| 0.109 | 0.042 | 0.138 | Opioid antagonist | 0.115 0.038 DB00279 0.138 0.029 DBMET02273 0.109 0.042 DBMET02578 | DBMET02273 | |
| 0.141 | 0.074 | 0.203 | Protein kinase stimulant | 0.142 0.074 DB00279 0.203 0.041 DBMET02273 0.141 0.075 DBMET02578 | DBMET02273 | |
| 0.107 | 0.041 | 0.118 | Triose-phosphate isomerase inhibitor | 0.106 0.042 DB00279 0.118 0.034 DBMET02273 0.105 0.043 DBMET02578 | DBMET02273 | |
| 0.098 | 0.032 | 0.121 | Opioid mu receptor antagonist | 0.104 0.03 DB00279 0.121 0.024 DBMET02273 0.097 0.033 DBMET02578 | DBMET02273 | |
| 0.07 | 0.005 | 0.073 | Glutamate (mGluR8) agonist | 0.066 0.005 DB00279 0.073 0.004 DBMET02273 0.064 0.006 DBMET02578 | DBMET02273 | |
| 0.069 | 0.005 | 0.076 | NMDA 2D receptor antagonist | 0.066 0.005 DB00279 0.076 0.004 DBMET02273 0.066 0.005 DBMET02578 | DBMET02273 | |
| 0.101 | 0.038 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.101 0.039 DB00279 0.105 0.033 DBMET02273 0.101 0.039 DBMET02578 | DBMET02273 | |
| 0.067 | 0.004 | 0.068 | Glutamate (mGluR8) antagonist | 0.065 0.004 DB00279 0.068 0.004 DBMET02273 0.065 0.005 DBMET02578 | DBMET02273 | |
| 0.099 | 0.037 | 0.135 | Adrenaline agonist | 0.083 0.054 DB00279 0.135 0.019 DBMET02273 0.109 0.031 DBMET02578 | DBMET02273 | |
| 0.073 | 0.011 | 0.073 | CXC chemokine 1 receptor antagonist | 0.049 0.04 DB00279 0.071 0.012 DBMET02578 | ||
| 0.066 | 0.005 | 0.083 | AMPA 3 receptor antagonist | 0.058 0.006 DB00279 0.083 0.004 DBMET02273 0.055 0.007 DBMET02578 | DBMET02273 | |
| 0.065 | 0.005 | 0.066 | Kainate receptor 5 antagonist | 0.057 0.005 DB00279 0.066 0.005 DBMET02273 0.052 0.005 DBMET02578 | DBMET02273 | |
| 0.063 | 0.004 | 0.069 | Tryptophan 5 hydroxylase inhibitor | 0.062 0.004 DB00279 0.069 0.003 DBMET02273 0.064 0.004 DBMET02578 | DBMET02273 | |
| 0.071 | 0.012 | 0.19 | Growth hormone release inhibitor | 0.19 0.004 DB00279 0.08 0.009 DBMET02273 0.068 0.012 DBMET02578 | DB00279 | |
| 0.112 | 0.054 | 0.112 | Protease inhibitor | 0.097 0.068 DB00279 0.111 0.055 DBMET02273 0.11 0.056 DBMET02578 | ||
| 0.071 | 0.016 | 0.08 | Beta 2 adrenoreceptor antagonist | 0.059 0.024 DB00279 0.08 0.012 DBMET02273 0.075 0.014 DBMET02578 | DBMET02273 | |
| 0.141 | 0.088 | 0.142 | Anticoagulant | 0.12 0.112 DB00279 0.142 0.088 DBMET02273 0.136 0.094 DBMET02578 | DBMET02273 | |
| 0.109 | 0.057 | 0.161 | Carbonic anhydrase XV inhibitor | 0.111 0.054 DB00279 0.161 0.027 DBMET02273 0.112 0.053 DBMET02578 | DBMET02273 | |
| 0.063 | 0.013 | 0.063 | Retinoid X receptor agonist | 0.038 0.024 DB00279 0.039 0.023 DBMET02578 | ||
| 0.079 | 0.028 | 0.091 | Beta adrenoreceptor antagonist | 0.067 0.042 DB00279 0.091 0.02 DBMET02273 0.084 0.024 DBMET02578 | DBMET02273 | |
| 0.056 | 0.006 | 0.057 | Kainate receptor 4 antagonist | 0.051 0.007 DB00279 0.057 0.005 DBMET02273 0.047 0.007 DBMET02578 | DBMET02273 | |
| 0.076 | 0.026 | 0.085 | Prostaglandin F2 alpha antagonist | 0.076 0.026 DB00279 0.085 0.019 DBMET02273 0.075 0.027 DBMET02578 | DBMET02273 | |
| 0.058 | 0.009 | 0.073 | Purinergic P2X3 antagonist | 0.073 0.005 DB00279 0.056 0.009 DBMET02578 | DB00279 | |
| 0.07 | 0.022 | 0.104 | Integrin antagonist | 0.081 0.019 DB00279 0.104 0.016 DBMET02273 0.061 0.024 DBMET02578 | DBMET02273 | |
| 0.061 | 0.014 | 0.069 | AICAR transformylase inhibitor | 0.057 0.016 DB00279 0.069 0.01 DBMET02273 0.057 0.016 DBMET02578 | DBMET02273 | |
| 0.088 | 0.042 | 0.106 | Porphobilinogen synthase inhibitor | 0.086 0.043 DB00279 0.106 0.033 DBMET02273 0.081 0.047 DBMET02578 | DBMET02273 | |
| 0.054 | 0.007 | 0.059 | VCAM-1 antagonist | 0.054 0.007 DB00279 0.059 0.005 DBMET02273 0.053 0.007 DBMET02578 | DBMET02273 | |
| 0.054 | 0.007 | 0.059 | VCAM antagonist | 0.053 0.007 DB00279 0.059 0.005 DBMET02273 0.053 0.007 DBMET02578 | DBMET02273 | |
| 0.071 | 0.024 | 0.076 | Botulinum neurotoxin type A inhibitor | 0.069 0.026 DB00279 0.076 0.02 DBMET02273 0.07 0.025 DBMET02578 | DBMET02273 | |
| 0.115 | 0.072 | 0.152 | Adenylate cyclase inhibitor | 0.11 0.076 DB00279 0.152 0.044 DBMET02273 0.11 0.076 DBMET02578 | DBMET02273 | |
| 0.072 | 0.029 | 0.082 | Aminopeptidase microsomal inhibitor | 0.071 0.031 DB00279 0.082 0.024 DBMET02273 0.071 0.031 DBMET02578 | DBMET02273 | |
| 0.078 | 0.036 | 0.089 | Glucagon-like peptide 1 agonist | 0.088 0.029 DB00279 0.089 0.029 DBMET02273 0.077 0.037 DBMET02578 | DBMET02273 | |
| 0.151 | 0.109 | 0.184 | Hepatoprotectant | 0.15 0.11 DB00279 0.184 0.076 DBMET02273 0.147 0.113 DBMET02578 | DBMET02273 | |
| 0.058 | 0.016 | 0.066 | Somatostatin 1 antagonist | 0.066 0.013 DB00279 0.042 0.025 DBMET02273 0.055 0.017 DBMET02578 | DB00279 | |
| 0.07 | 0.029 | 0.07 | Cathepsin B inhibitor | 0.052 0.046 DBMET02273 0.066 0.031 DBMET02578 | ||
| 0.18 | 0.139 | 0.227 | Interleukin agonist | 0.178 0.141 DB00279 0.227 0.097 DBMET02273 0.177 0.142 DBMET02578 | DBMET02273 | |
| 0.051 | 0.012 | 0.103 | Somatostatin 5 agonist | 0.103 0.005 DB00279 0.057 0.01 DBMET02273 0.049 0.013 DBMET02578 | DB00279 | |
| 0.065 | 0.026 | 0.077 | Urokinase inhibitor | 0.064 0.026 DB00279 0.077 0.022 DBMET02273 0.064 0.026 DBMET02578 | DBMET02273 | |
| 0.05 | 0.011 | 0.076 | Integrin alpha4 antagonist | 0.064 0.009 DB00279 0.076 0.008 DBMET02273 0.045 0.012 DBMET02578 | DBMET02273 | |
| 0.062 | 0.024 | 0.093 | Phosphorylase inhibitor | 0.057 0.026 DB00279 0.093 0.014 DBMET02273 0.056 0.027 DBMET02578 | DBMET02273 | |
| 0.068 | 0.03 | 0.12 | Alcohol oxidase inhibitor | 0.068 0.03 DB00279 0.12 0.014 DBMET02273 0.061 0.034 DBMET02578 | DBMET02273 | |
| 0.099 | 0.061 | 0.149 | Creatine kinase inhibitor | 0.106 0.053 DB00279 0.149 0.024 DBMET02273 0.101 0.059 DBMET02578 | DBMET02273 | |
| 0.044 | 0.007 | 0.052 | Glutamate (mGluR3) agonist | 0.044 0.007 DB00279 0.052 0.004 DBMET02273 0.044 0.007 DBMET02578 | DBMET02273 | |
| 0.048 | 0.012 | 0.082 | AMPA 1 receptor antagonist | 0.041 0.014 DB00279 0.082 0.007 DBMET02273 0.037 0.016 DBMET02578 | DBMET02273 | |
| 0.087 | 0.052 | 0.091 | D-Ala-D-Ala ligase inhibitor | 0.089 0.046 DB00279 0.091 0.043 DBMET02273 0.091 0.043 DBMET02578 | DBMET02578 | |
| 0.069 | 0.035 | 0.099 | Beta 3 adrenoreceptor antagonist | 0.072 0.031 DB00279 0.099 0.015 DBMET02273 0.072 0.03 DBMET02578 | DBMET02273 | |
| 0.093 | 0.06 | 0.138 | Alcohol dehydrogenase inhibitor | 0.093 0.06 DB00279 0.138 0.025 DBMET02273 0.092 0.062 DBMET02578 | DBMET02273 | |
| 0.048 | 0.017 | 0.049 | Membrane dipeptidase inhibitor | 0.044 0.021 DB00279 0.049 0.017 DBMET02273 0.042 0.024 DBMET02578 | DBMET02273 | |
| 0.099 | 0.07 | 0.132 | Expectorant | 0.102 0.067 DB00279 0.132 0.043 DBMET02273 0.099 0.07 DBMET02578 | DBMET02273 | |
| 0.034 | 0.005 | 0.035 | Kainate receptor 3 antagonist | 0.03 0.005 DB00279 0.035 0.005 DBMET02273 0.028 0.005 DBMET02578 | DBMET02273 | |
| 0.035 | 0.006 | 0.041 | Beta 1 adrenoreceptor agonist | 0.029 0.009 DB00279 0.041 0.005 DBMET02273 0.038 0.005 DBMET02578 | DBMET02273 | |
| 0.173 | 0.144 | 0.227 | Calpain inhibitor | 0.169 0.15 DB00279 0.227 0.088 DBMET02273 0.173 0.144 DBMET02578 | DBMET02273 | |
| 0.064 | 0.036 | 0.072 | Plasminogen activator inhibitor | 0.063 0.037 DB00279 0.072 0.03 DBMET02273 0.064 0.037 DBMET02578 | DBMET02273 | |
| 0.046 | 0.018 | 0.056 | Arginase inhibitor | 0.043 0.02 DB00279 0.056 0.012 DBMET02273 0.04 0.022 DBMET02578 | DBMET02273 | |
| 0.14 | 0.113 | 0.193 | Amyloid beta precursor protein antagonist | 0.142 0.111 DB00279 0.193 0.062 DBMET02273 0.143 0.109 DBMET02578 | DBMET02273 | |
| 0.099 | 0.072 | 0.099 | Ferrochelatase inhibitor | 0.099 0.072 DBMET02273 | ||
| 0.048 | 0.021 | 0.054 | Beta adrenoreceptor agonist | 0.045 0.031 DB00279 0.054 0.012 DBMET02273 0.05 0.017 DBMET02578 | DBMET02273 | |
| 0.045 | 0.019 | 0.049 | Carbonic anhydrase I stimulant | 0.043 0.021 DB00279 0.049 0.017 DBMET02273 0.042 0.022 DBMET02578 | DBMET02273 | |
| 0.058 | 0.033 | 0.063 | Angiotensin-converting enzyme inhibitor | 0.061 0.029 DB00279 0.063 0.026 DBMET02273 0.056 0.035 DBMET02578 | DBMET02273 | |
| 0.059 | 0.035 | 0.064 | Kallikrein 1 inhibitor | 0.059 0.036 DB00279 0.064 0.029 DBMET02273 0.059 0.035 DBMET02578 | DBMET02273 | |
| 0.032 | 0.009 | 0.033 | Complement factor 1r inhibitor | 0.032 0.009 DB00279 0.033 0.008 DBMET02273 0.031 0.009 DBMET02578 | DBMET02273 | |
| 0.041 | 0.018 | 0.042 | Integrin alpha1beta1 antagonist | 0.041 0.02 DB00279 0.042 0.017 DBMET02273 0.04 0.02 DBMET02578 | DBMET02273 | |
| 0.051 | 0.031 | 0.059 | Aminopeptidase N inhibitor | 0.05 0.032 DB00279 0.059 0.025 DBMET02273 0.049 0.032 DBMET02578 | DBMET02273 | |
| 0.045 | 0.025 | 0.055 | Erythropoietin receptor agonist | 0.045 0.024 DB00279 0.055 0.019 DBMET02273 0.044 0.025 DBMET02578 | DBMET02273 | |
| 0.029 | 0.009 | 0.036 | Integrin alpha4beta7 antagonist | 0.028 0.009 DB00279 0.036 0.007 DBMET02273 0.028 0.009 DBMET02578 | DBMET02273 | |
| 0.062 | 0.043 | 0.072 | Beta 2 adrenoreceptor agonist | 0.063 0.037 DB00279 0.072 0.016 DBMET02273 0.064 0.035 DBMET02578 | DBMET02273 | |
| 0.106 | 0.088 | 0.169 | Aldehyde dehydrogenase inhibitor | 0.108 0.086 DB00279 0.169 0.037 DBMET02273 0.108 0.085 DBMET02578 | DBMET02273 | |
| 0.108 | 0.09 | 0.203 | Amylase inhibitor | 0.112 0.087 DB00279 0.203 0.043 DBMET02273 0.112 0.086 DBMET02578 | DBMET02273 | |
| 0.024 | 0.006 | 0.04 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.04 0.004 DB00279 0.022 0.007 DBMET02273 0.021 0.007 DBMET02578 | DB00279 | |
| 0.029 | 0.011 | 0.034 | Glutamate (mGluR1) agonist | 0.026 0.015 DB00279 0.034 0.007 DBMET02273 0.025 0.017 DBMET02578 | DBMET02273 | |
| 0.087 | 0.069 | 0.104 | HIV-1 integrase (Overall Integration) inhibitor | 0.088 0.067 DB00279 0.104 0.051 DBMET02273 0.093 0.061 DBMET02578 | DBMET02273 | |
| 0.046 | 0.029 | 0.052 | Complement C3a chemotactic receptor antagonist | 0.044 0.03 DB00279 0.052 0.026 DBMET02273 0.044 0.03 DBMET02578 | DBMET02273 | |
| 0.051 | 0.035 | 0.051 | Thromboxane A2 antagonist | 0.049 0.037 DB00279 0.045 0.041 DBMET02273 0.051 0.036 DBMET02578 | ||
| 0.052 | 0.036 | 0.053 | Carbonic anhydrase II stimulant | 0.051 0.038 DB00279 0.053 0.034 DBMET02273 0.05 0.04 DBMET02578 | DBMET02273 | |
| 0.049 | 0.033 | 0.049 | Dopamine transporter inhibitor | 0.047 0.034 DB00279 0.048 0.034 DBMET02578 | ||
| 0.035 | 0.019 | 0.039 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DB00279 0.039 0.015 DBMET02273 0.034 0.021 DBMET02578 | DBMET02273 | |
| 0.07 | 0.054 | 0.099 | Cathepsin G inhibitor | 0.068 0.055 DB00279 0.099 0.033 DBMET02273 0.071 0.053 DBMET02578 | DBMET02273 | |
| 0.077 | 0.062 | 0.079 | Glycine receptor antagonist | 0.079 0.059 DBMET02273 | DBMET02273 | |
| 0.093 | 0.078 | 0.101 | Folate antagonist | 0.092 0.083 DB00279 0.101 0.063 DBMET02273 0.092 0.082 DBMET02578 | DBMET02273 | |
| 0.129 | 0.114 | 0.155 | Interferon gamma antagonist | 0.13 0.111 DB00279 0.155 0.072 DBMET02273 0.127 0.117 DBMET02578 | DBMET02273 | |
| 0.019 | 0.004 | 0.02 | Glutamate (mGluR6) agonist | 0.017 0.005 DB00279 0.02 0.004 DBMET02273 0.016 0.005 DBMET02578 | DBMET02273 | |
| 0.027 | 0.013 | 0.052 | Somatostatin 4 antagonist | 0.052 0.008 DB00279 0.024 0.017 DBMET02273 0.026 0.014 DBMET02578 | DB00279 | |
| 0.065 | 0.052 | 0.074 | Sirtuin 1 inhibitor | 0.064 0.052 DB00279 0.074 0.041 DBMET02273 0.063 0.054 DBMET02578 | DBMET02273 | |
| 0.029 | 0.016 | 0.036 | Lysine carboxypeptidase inhibitor | 0.027 0.018 DB00279 0.036 0.012 DBMET02273 0.027 0.019 DBMET02578 | DBMET02273 | |
| 0.052 | 0.04 | 0.057 | Alpha-mannosidase inhibitor | 0.049 0.046 DB00279 0.057 0.031 DBMET02273 | DBMET02273 | |
| 0.049 | 0.038 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.05 0.036 DB00279 0.055 0.028 DBMET02273 0.05 0.036 DBMET02578 | DBMET02273 | |
| 0.026 | 0.016 | 0.031 | NMDA receptor glycine site antagonist | 0.023 0.019 DB00279 0.031 0.012 DBMET02273 | DBMET02273 | |
| 0.068 | 0.059 | 0.079 | Peroxisome proliferator-activated receptor gamma antagonist | 0.07 0.053 DB00279 0.079 0.035 DBMET02273 0.071 0.05 DBMET02578 | DBMET02273 | |
| 0.073 | 0.064 | 0.09 | Cell adhesion molecule inhibitor | 0.071 0.068 DB00279 0.09 0.042 DBMET02273 0.071 0.068 DBMET02578 | DBMET02273 | |
| 0.03 | 0.023 | 0.068 | Somatostatin 5 antagonist | 0.068 0.009 DB00279 0.042 0.017 DBMET02273 0.028 0.025 DBMET02578 | DB00279 | |
| 0.014 | 0.009 | 0.016 | Integrin beta6 antagonist | 0.014 0.01 DB00279 0.016 0.007 DBMET02273 0.014 0.01 DBMET02578 | DBMET02273 | |
| 0.019 | 0.014 | 0.025 | Integrin beta7 antagonist | 0.019 0.014 DB00279 0.025 0.011 DBMET02273 0.019 0.014 DBMET02578 | DBMET02273 | |
| 0.053 | 0.048 | 0.053 | Biliverdin reductase inhibitor | 0.053 0.048 DBMET02273 | ||
| 0.104 | 0.099 | 0.147 | Toll-Like receptor 2 antagonist | 0.106 0.095 DB00279 0.147 0.054 DBMET02273 0.105 0.096 DBMET02578 | DBMET02273 | |
| 0.048 | 0.044 | 0.048 | Thromboxane antagonist | 0.047 0.046 DB00279 0.048 0.044 DBMET02578 | ||
| 0.122 | 0.119 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | 0.125 0.113 DB00279 0.143 0.074 DBMET02273 0.126 0.11 DBMET02578 | DBMET02273 | |
| 0.051 | 0.048 | 0.052 | Dopamine uptake inhibitor | 0.05 0.049 DB00279 0.052 0.047 DBMET02273 0.052 0.046 DBMET02578 | DBMET02578 | |
| 0.019 | 0.015 | 0.041 | Somatostatin 3 antagonist | 0.041 0.008 DB00279 | DB00279 | |
| 0.024 | 0.022 | 0.033 | Urotensin II agonist | 0.033 0.013 DB00279 0.031 0.015 DBMET02273 0.024 0.022 DBMET02578 | DB00279 | |
| 0.057 | 0.055 | 0.072 | Neutrophil collagenase inhibitor | 0.058 0.053 DB00279 0.072 0.038 DBMET02273 0.058 0.053 DBMET02578 | DBMET02273 | |
| 0.029 | 0.027 | 0.039 | Prostacyclin antagonist | 0.031 0.025 DB00279 0.039 0.019 DBMET02273 0.031 0.025 DBMET02578 | DBMET02273 | |
| 0.039 | 0.038 | 0.049 | Neurotensin receptor antagonist | 0.039 0.038 DB00279 0.049 0.029 DBMET02273 | DBMET02273 | |
| 0.016 | 0.015 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DBMET02273 | DBMET02273 | |
| 0.048 | 0.048 | 0.053 | Vanilloid 2 antagonist | 0.049 0.046 DB00279 0.053 0.035 DBMET02273 0.049 0.044 DBMET02578 | DBMET02273 | |
| 0.009 | 0.011 | 0.013 | Beta 3 adrenoreceptor agonist | 0.013 0.007 DBMET02273 0.01 0.009 DBMET02578 | DBMET02273 | |
| 0.02 | 0.023 | 0.026 | ICAM 1 antagonist | 0.026 0.01 DBMET02273 | DBMET02273 | |
| 0.038 | 0.041 | 0.043 | Endothelin-converting enzyme inhibitor | 0.043 0.036 DBMET02273 | DBMET02273 | |
| 0.039 | 0.042 | 0.043 | Antimetabolite | 0.043 0.037 DBMET02273 | DBMET02273 | |
| 0.029 | 0.033 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.043 0.016 DBMET02273 0.046 0.015 DBMET02578 | DBMET02578 | |
| 0.02 | 0.024 | 0.066 | Somatostatin 2 antagonist | 0.066 0.01 DB00279 0.034 0.019 DBMET02273 | DB00279 | |
| 0.011 | 0.016 | 0.014 | Integrin alphaVbeta6 antagonist | 0.014 0.01 DBMET02273 | DBMET02273 | |
| 0.018 | 0.023 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.017 DBMET02273 | DBMET02273 | |
| 0.038 | 0.043 | 0.044 | Mannosidase inhibitor | 0.044 0.033 DBMET02273 | DBMET02273 | |
| 0.123 | 0.128 | 0.157 | Melanin inhibitor | 0.127 0.119 DB00279 0.157 0.072 DBMET02273 0.129 0.116 DBMET02578 | DBMET02273 | |
| 0.019 | 0.025 | 0.044 | Sigma 1 receptor antagonist | 0.044 0.011 DB00279 | DB00279 | |
| 0.019 | 0.026 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 DBMET02273 | DBMET02273 | |
| 0.158 | 0.165 | 0.249 | Hypoglycemic | 0.167 0.152 DB00279 0.249 0.078 DBMET02273 0.168 0.15 DBMET02578 | DBMET02273 | |
| 0.032 | 0.038 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.023 DBMET02273 | DBMET02273 | |
| 0.083 | 0.09 | 0.113 | Interleukin 12 antagonist | 0.086 0.083 DB00279 0.113 0.036 DBMET02273 0.086 0.081 DBMET02578 | DBMET02273 | |
| 0.028 | 0.036 | 0.033 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET02273 | DBMET02273 | |
| 0.063 | 0.072 | 0.086 | Metalloproteinase-9 inhibitor | 0.086 0.04 DBMET02273 | DBMET02273 | |
| 0.037 | 0.046 | 0.048 | Thymidylate synthase inhibitor | 0.048 0.031 DB00279 0.047 0.031 DBMET02273 | DB00279 | |
| 0.046 | 0.056 | 0.062 | Sphingosine kinase 2 inhibitor | 0.062 0.029 DBMET02273 | DBMET02273 | |
| 0.08 | 0.09 | 0.154 | Monophenol monooxygenase inhibitor | 0.092 0.082 DB00279 0.154 0.045 DBMET02273 0.097 0.078 DBMET02578 | DBMET02273 | |
| 0.024 | 0.035 | 0.038 | HCV NS5B polymerase inhibitor | 0.038 0.015 DBMET02273 0.038 0.015 DBMET02578 | DBMET02578 | |
| 0.044 | 0.056 | 0.071 | Beta 1 adrenoreceptor antagonist | 0.071 0.025 DBMET02273 | DBMET02273 | |
| 0.027 | 0.04 | 0.031 | Peroxisome proliferator-activated receptor delta antagonist | 0.031 0.027 DBMET02273 | DBMET02273 | |
| 0.096 | 0.109 | 0.14 | Cyclooxygenase 3 inhibitor | 0.103 0.099 DB00279 0.14 0.057 DBMET02273 0.107 0.093 DBMET02578 | DBMET02273 | |
| 0.024 | 0.037 | 0.029 | Calcitonin receptor agonist | 0.029 0.028 DBMET02273 | DBMET02273 | |
| 0.025 | 0.039 | 0.031 | ATP citrate lysase inhibitor | 0.03 0.026 DB00279 0.031 0.023 DBMET02273 | DBMET02273 | |
| 0.051 | 0.066 | 0.088 | Sphingosine 1-phosphate receptor 4 agonist | 0.088 0.032 DBMET02273 | DBMET02273 | |
| 0.068 | 0.083 | 0.101 | Histamine N-methyltransferase inhibitor | 0.101 0.045 DBMET02273 | DBMET02273 | |
| 0.028 | 0.043 | 0.037 | Opioid delta receptor agonist | 0.037 0.022 DBMET02273 | DBMET02273 | |
| 0.185 | 0.201 | 0.261 | Apoptosis antagonist | 0.261 0.117 DBMET02273 | DBMET02273 | |
| 0.063 | 0.079 | 0.086 | Metalloproteinase-2 inhibitor | 0.086 0.047 DBMET02273 | DBMET02273 | |
| 0.069 | 0.086 | 0.086 | Glutathione S-transferase inhibitor | 0.086 0.052 DBMET02273 | DBMET02273 | |
| 0.03 | 0.047 | 0.044 | Dopamine D5 agonist | 0.044 0.023 DBMET02273 | DBMET02273 | |
| 0.066 | 0.084 | 0.086 | Opioid kappa receptor antagonist | 0.086 0.049 DBMET02273 | DBMET02273 | |
| 0.035 | 0.054 | 0.052 | AMPA receptor antagonist | 0.052 0.029 DBMET02273 | DBMET02273 | |
| 0.069 | 0.095 | 0.079 | Factor XII inhibitor | 0.079 0.068 DBMET02273 | DBMET02273 | |
| 0.075 | 0.102 | 0.101 | MAP kinase kinase 1 inhibitor | 0.101 0.055 DBMET02273 | DBMET02273 | |
| 0.084 | 0.111 | 0.121 | Alkylator | 0.121 0.067 DBMET02273 | DBMET02273 | |
| 0.032 | 0.059 | 0.048 | Opioid mu receptor agonist | 0.048 0.03 DBMET02273 | DBMET02273 | |
| 0.046 | 0.075 | 0.058 | Sphingosine kinase inhibitor | 0.058 0.042 DBMET02273 | DBMET02273 | |
| 0.071 | 0.104 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.047 DBMET02273 | DBMET02273 | |
| 0.085 | 0.12 | 0.131 | Tubulin antagonist | 0.125 0.075 DB00279 0.131 0.07 DBMET02273 | DBMET02273 | |
| 0.054 | 0.09 | 0.086 | Analgesic, opioid | 0.086 0.041 DBMET02273 | DBMET02273 | |
| 0.026 | 0.063 | 0.054 | Glycine transporter 2 inhibitor | 0.054 0.028 DBMET02273 | DBMET02273 | |
| 0.074 | 0.111 | 0.09 | Anabolic | 0.09 0.078 DBMET02273 | DBMET02273 | |
| 0.102 | 0.142 | 0.143 | Phospholipase A2 inhibitor | 0.143 0.082 DBMET02273 | DBMET02273 | |
| 0.125 | 0.167 | 0.242 | Aldehyde oxidase inhibitor | 0.242 0.085 DBMET02273 | DBMET02273 | |
| 0.082 | 0.126 | 0.109 | Caspase 3 inhibitor | 0.109 0.077 DBMET02273 | DBMET02273 | |
| 0.039 | 0.084 | 0.059 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.059 0.04 DBMET02273 | DBMET02273 | |
| 0.126 | 0.178 | 0.179 | Neurotrophic factor enhancer | 0.179 0.1 DBMET02273 | DBMET02273 | |
| 0.059 | 0.112 | 0.079 | Inducible nitric-oxide synthase inhibitor | 0.079 0.063 DBMET02273 | DBMET02273 | |
| 0.101 | 0.154 | 0.12 | Sphingosine 1-phosphate receptor 2 antagonist | 0.12 0.098 DBMET02273 | DBMET02273 | |
| 0.037 | 0.094 | 0.058 | Matrix metalloproteinase inhibitor | 0.058 0.057 DBMET02273 | DBMET02273 | |
| 0.068 | 0.125 | 0.103 | Carbonic anhydrase III inhibitor | 0.103 0.059 DBMET02273 | DBMET02273 | |
| 0.029 | 0.087 | 0.041 | Glucagon-like peptide 1 receptor antagonist | 0.041 0.024 DB00279 | DB00279 | |
| 0.131 | 0.191 | 0.217 | Antioxidant | 0.217 0.103 DBMET02273 | DBMET02273 | |
| 0.015 | 0.077 | 0.032 | Somatostatin agonist | 0.032 0.022 DB00279 | DB00279 | |
| 0.102 | 0.164 | 0.142 | Hemostatic | 0.142 0.079 DBMET02273 | DBMET02273 | |
| 0.181 | 0.245 | 0.236 | Calcium channel activator | 0.236 0.164 DBMET02273 | DBMET02273 | |
| 0.053 | 0.118 | 0.078 | Carbonic anhydrase VI inhibitor | 0.078 0.06 DBMET02273 | DBMET02273 | |
| 0.032 | 0.099 | 0.048 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.046 DBMET02273 | DBMET02273 | |
| 0.066 | 0.14 | 0.091 | Xanthine oxidase inhibitor | 0.091 0.07 DBMET02273 | DBMET02273 | |
| 0.064 | 0.138 | 0.083 | Thioredoxin inhibitor | 0.083 0.075 DBMET02273 | DBMET02273 | |
| 0.102 | 0.177 | 0.145 | Anesthetic general | 0.145 0.12 DBMET02273 | DBMET02273 | |
| 0.057 | 0.132 | 0.07 | GABA B receptor agonist | 0.07 0.068 DBMET02273 | DBMET02273 | |
| 0.068 | 0.159 | 0.122 | Bone formation stimulant | 0.122 0.084 DBMET02273 | DBMET02273 | |
| 0.143 | 0.237 | 0.168 | Nitric-oxide synthase stimulant | 0.168 0.158 DBMET02273 | DBMET02273 | |
| 0.074 | 0.171 | 0.114 | Estrogen antagonist | 0.114 0.066 DBMET02273 | DBMET02273 | |
| 0.083 | 0.187 | 0.115 | Diuretic | 0.115 0.111 DBMET02273 | DBMET02273 | |
| 0.07 | 0.177 | 0.108 | Alkaline phosphatase inhibitor | 0.108 0.102 DBMET02273 | DBMET02273 | |
| 0.068 | 0.179 | 0.12 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET02273 | DBMET02273 | |
| 0.186 | 0.298 | 0.292 | Calcium channel L-type activator | 0.292 0.164 DBMET02273 | DBMET02273 | |
| 0.114 | 0.242 | 0.129 | Heat shock protein 70 antagonist | 0.129 0.125 DBMET02273 | DBMET02273 | |
| 0.075 | 0.259 | 0.166 | Interleukin antagonist | 0.166 0.107 DBMET02273 | DBMET02273 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |